Researchers find new, drug-resistant strain of salmonella
|
|
Doctors at the Centers for Disease Control and Prevention are worried about a strain of salmonella that resists all but one antibiotic
| |
In this story:
May 6, 1998
Web posted at: 6:30 p.m. EDT (2230 GMT)
ATLANTA (CNN) -- Researchers report that a dangerous new strain of salmonella has emerged in the past decade that infects thousands of people each year and does not respond to
most antibiotics.
According to their study, reported in Thursday's New England
Journal of Medicine, laboratories across the United States
found that the new strain of salmonella is resistant to five
common antibiotics, and responds to only one.
"What we found ... is that a particular organism, which has a
kind of unwieldy name -- salmonella typhimurium, or DT104 --
is resistant to five common antimicrobial agents and has
emerged right in front of our eyes in about the past 10
years," said Dr. Kathleen Glynn of the Centers for Disease Control and Prevention in Atlanta.
Using data from three sources, Glynn and her colleagues
estimated the resistant bacteria were infecting between
68,000 and 340,000 people of the estimated 4 million people
infected with salmonella each year.
Salmonella infections kill about 500 people annually.
Most people recover from the illness on their own,
researchers say, but they found that if the illness became
severe and medication were needed, most of the antibiotics
would be ineffective against DT 104.
DT 104 does respond to one type of antibiotic called
fluroquinolines, but researchers worry that it, too, might
develop a resistance to fluroquinolines.
"We want to make sure that the agents that are useful in
treating this illness today are also useful in treating this
illness a year from now," Glynn said.
|
|
The low levels of antibiotics in animal feed give bacteria in some animals a chance to develop resistance
| |
Antibiotics in animal feed blamed
Salmonella is caused by eating contaminated food and is
characterized by sharp stomach pains, fever and diarrhea that
usually lasts from two to five days.
Ordinarily, salmonella infections are not considered serious,
but if one becomes severe, antibiotics can save a person's
life.
Researchers have warned for more than a decade that the
practice of speeding animal growth by adding common
antibiotics to livestock food was fostering the evolution of
drug-resistant bacteria, but it is still common today.
More than 16 million of the 50 million pounds of antibiotics
produced in the United States each year are combined with
animal food so the animals will grow faster.
In the United Kingdom "DT104 now appears to be widely
distributed in food animals, particularly cattle, and
investigations have associated infections in humans with
eating pork sausages, chicken and meat paste, and with
contact with sick animals," the researchers said.
|
|
Antibiotics can save a patient's life
| |
Strain resists 7 European antibiotics
The low levels of antibiotics in animal feed give bacteria in
the animals a chance to develop resistance. And once bacteria
develop a resistance to one antibiotic, they rapidly learn to
resist others as well, said Dr. Stuart B. Levy of Tufts
University School of Medicine in an editorial accompanying
the report.
"The DT104 strain, whose frequency is rising in the United
States, has been plaguing animals and people in Europe for
the past decade," Levy said. "There, the organism has
acquired resistance to seven drugs that are used to combat
it."
Last year, an expert panel of the World Health Organization
repeated the call for a ban on the use of human antibiotics
to promote the growth of livestock. The group also called for
careful use of antibiotics to stop diseases in food animals.
"We need to minimize the environmental impact of
antibiotics," Levy said.
He said doctors should stop giving them to humans who have
viral infections, for which the drugs are ineffective anyway,
and their use in animals should be limited.
The researchers also called for "prudent use of microbial
agents in farm animals."
Correspondent Elizabeth Cohen and Reuters contributed to this report.